Nervous

U.S. adults are still behind on routine cancer screenings—but reasons why vary by race

Retrieved on: 
Tuesday, April 2, 2024
Lung cancer, Health, Millennials, Child care, Confusion, Prostate cancer, Survival, Skin cancer, Disease, Colorectal cancer, Nervous, Risk, Cervical cancer, Heredity, Education, Patient, Cancer, Testicular cancer, Oral cancer, Generation Z, Breast cancer, Gen, Fear

The survey revealed that nearly seven in 10 U.S. adults are behind on at least one routine cancer screening.1

Key Points: 
  • The survey revealed that nearly seven in 10 U.S. adults are behind on at least one routine cancer screening.1
    The second annual survey, released during Cancer Prevention and Early Detection Month in April, indicates more U.S. adults are behind on routine cancer screenings compared to last year.
  • It is crucial to advocate for your health and talk to your health care provider about the routine cancer screenings you need.
  • “We are reaffirming our commitment to empowering people to stay ahead of cancer through prevention and early detection until all populations can achieve better outcomes—without any barriers to the process.”
    1The cancer screenings studied in this survey were for breast cancer, cervical cancer, colorectal cancer, lung cancer, oral cancer, prostate cancer, skin cancer and testicular cancer.
  • 2In this survey, Gen Z is defined as adults ages 21-27 and Millennials are defined as adults ages 28-43.

Oklahoma Proton Center Celebrates Milestone Achievement: 5,000th Patient Successfully Treated

Retrieved on: 
Tuesday, April 2, 2024
Brain, Proton therapy, Nervous, Education, Patient, Lung, Research, Breast, Prostate, Health, Medical imaging

OKLAHOMA CITY, April 2, 2024 /PRNewswire/ -- In a momentous occasion, Oklahoma Proton Center, a leading provider of cutting-edge proton therapy, recently completed treatment on their 5,000th patient.

Key Points: 
  • OKLAHOMA CITY, April 2, 2024 /PRNewswire/ -- In a momentous occasion, Oklahoma Proton Center, a leading provider of cutting-edge proton therapy, recently completed treatment on their 5,000th patient.
  • Oklahoma Proton Center is one of a few proton centers in the country to reach the 5,000 patient milestone.
  • The Oklahoma Proton Center treats over 600 patients annually from around Oklahoma and across multiple disease sites.
  • Dr. John Chang, Medical Director at Oklahoma Proton Center remarked, "Reaching the milestone of treating our 5000th patient is a moment of great pride for our team.

True Value Empowers DIYers and Local Retailers with First Campaign in Decade

Retrieved on: 
Tuesday, April 2, 2024
True Value, Laughlin Constable, Partnership, Nervous, Juke Box Hero, Multimedia, SVP, DIY, Frustration, Video game

CHICAGO, April 2, 2024 /PRNewswire/ -- True Value, the iconic hardware store brand with a rich legacy spanning 75 years, proudly announces the launch of its "Hardware Hero" campaign in partnership with its agency of record Laughlin Constable. At a time when retail is down across industries, and consumers are pinching pennies, True Value is leveraging its legacy brand, deep expertise, and operational scale to ensure independent home improvement retailers thrive.

Key Points: 
  • At a time when retail is down across industries, and consumers are pinching pennies, True Value is leveraging its legacy brand, deep expertise, and operational scale to ensure independent home improvement retailers thrive.
  • "Every part of the home improvement process is empowering, and it's so satisfying to be the champion of your domain.
  • Campaign creative utilizes a re-working of the famous '80s song "Jukebox Hero" to turn everyday homeowners into hardware, lawncare and paint heroes.
  • I think we nailed how welcoming your local True Value is, and that you are guaranteed to easily get expert advice and great products to keep your momentum going."

Advisory - Only use authorized nicotine pouches as directed, and do not use unauthorized nicotine pouches

Retrieved on: 
Wednesday, March 20, 2024
Palpitations, Varenicline, Chest pain, Xerostomia, Dizziness, Weakness, Caregiver, Nervous, Indigestion, Sleep, Risk, Headache, NPN, Health, Nicotine, Angina, Internet, Stroke, Constipation, Smoke, Death, Heartburn, Health Canada, Arrhythmia, Nausea, Medicine, Nursing, Safety, Fatigue, Vomiting, Blurred vision, Allergy, Parent, Chronic pain, Advertising, Tobacco

Consuming multiple nicotine products at the same time, including authorized nicotine replacement therapy products, or varenicline (a prescription smoking cessation drug), may increase the adverse effects of nicotine.

Key Points: 
  • Consuming multiple nicotine products at the same time, including authorized nicotine replacement therapy products, or varenicline (a prescription smoking cessation drug), may increase the adverse effects of nicotine.
  • Use authorized nicotine pouches only as directed:
    To date, Health Canada has authorized only one nicotine pouch , containing 4 mg of nicotine per dose.
  • Nicotine replacement therapies, including nicotine pouches, are not authorized for recreational use or for use by nonsmokers and people under 18 years old.
  • There are no authorized nicotine pouches in Canada that contain more than 4 mg of nicotine per dose.

Two-Fold Increase in Absenteeism among Caregivers with a Child with Mental Health Needs, According to Integrated Benefits Institute Analysis

Retrieved on: 
Monday, March 4, 2024
Grammatical mood, Social media, Nervous, Mental health, Caregiver, Performance, Workplace, Absenteeism, Work, Sleep, Disease, IBI, Health, Presenteeism, Smartphone, Child, Sadness, Restless, Residential care

The survey found a significant connection between caregiving for a child with mental health needs and an increase in absenteeism and presenteeism in the workplace.

Key Points: 
  • The survey found a significant connection between caregiving for a child with mental health needs and an increase in absenteeism and presenteeism in the workplace.
  • IBI's survey found that caregivers with severe mental distress are more likely to have a child who needs mental health treatment.
  • Thirty-four percent of caregivers reported experiencing "severe mental distress" have a child who needs mental health treatment, compared to 15% of those whose child does not need treatment.
  • There was a two-fold increase in absenteeism among caregivers with a child with mental health needs.

Chicago Auto Show's Seventh Annual "What Drives Her" Award Finalists Announced

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Anxiety, Nervous, McCormick Place, Research, Environment, BMW Motorrad, EV, Organization, Social media, Female, Human, Education, Empowerment, BMW, CDK Global, Reiss, Chicago Auto Show, CDK, Management

CHICAGO, Jan. 31, 2024 /PRNewswire/ -- Chicago Auto Show organizers, in partnership with A Girls Guide to Cars and Women in Automotive, have announced the seventh annual What Drives Her networking event and awards program, presented by Nissan, during the show's Media Preview on Thursday, Feb. 8 at McCormick Place.

Key Points: 
  • What Drives Her will recognize women who are changing the auto industry and the advocates who help make change happen.
  • Productions Plus conducted a survey* exclusively targeted to female Chicago Auto Show attendees from 2023 and found that 95% of previous attendees are heading back to the auto show.
  • The What Drives Her program and awards ceremony, presented by Nissan and sponsored by CDK Global, will also be livestreamed on the Chicago Auto Show Facebook page .
  • *The Productions Plus What Drives Her Survey is an online survey of 2,708 2023 Chicago Auto Show attendees conducted in January 2024.

Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 16, Status: Authorised

Retrieved on: 
Friday, January 5, 2024
Medical Subject Headings, Marketing, European Commission, Agency, Neuropathic pain, INN, Risk, ATC, Capsule, International, European, Spinal cord, Language, Butyric acid, Brain, Anxiety disorder, Anxiety, GAD, Nervous, Peripheral neuropathy, Zentiva, Select, Committee, Patient, Risk management, Anatomy, Medicine, IIA, CHMP, Medical device

Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 16, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 62, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Patient, Medical Subject Headings, Marketing, European Commission, Neuropathic pain, INN, Tetraplegia, Allergy, ATC, Pain, Capsule, International, European, Spinal cord, Language, Brain, Somnolence, Shingles, Diabetes, Anxiety disorder, Nerve, Dizziness, Anxiety, Anticonvulsant, Water, GAD, Nervous, Peripheral neuropathy, Diabetic neuropathy, Select, Committee, Anatomy, Medicine, Chronic pain, Seizure, IIA, CHMP, Medical device

Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 62, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 62, Status: Authorised

Human medicines European public assessment report (EPAR): Pregabalin Pfizer, pregabalin, Date of authorisation: 10/04/2014, Revision: 30, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Patient, Medical Subject Headings, Marketing, Pfizer, European Commission, Agency, Neuropathic pain, INN, ATC, Pain, Capsule, International, European, Spinal cord, Diabetes, Language, Butyric acid, Brain, Somnolence, Shingles, Anxiety disorder, Nerve, Dizziness, Anxiety, Water, GAD, Nervous, CHMP, Peripheral neuropathy, Select, Risk management, Anatomy, Medicine, Chronic pain, Seizure, IIA, Pharmaceutical industry

Human medicines European public assessment report (EPAR): Pregabalin Pfizer, pregabalin, Date of authorisation: 10/04/2014, Revision: 30, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Pregabalin Pfizer, pregabalin, Date of authorisation: 10/04/2014, Revision: 30, Status: Authorised

EQS-News: Why Pulsar Helium has game-changing potential for the US helium industry

Retrieved on: 
Saturday, December 30, 2023
PLSR, Risk, Helium, Sale, News, Research, WhatsApp, Acquisition, Hydrocarbon, FRA, Anglo-French Wars, USD, Pulsar, Nervous, Natural gas, Advertising, GameChanger, Lithium

With recent sales of liquid helium exceeding USD $1,000 per thousand cubic feet whereas natural gas is ~USD $4.

Key Points: 
  • With recent sales of liquid helium exceeding USD $1,000 per thousand cubic feet whereas natural gas is ~USD $4.
  • (see below)
    Conclusion: Pulsar is one of a handful of helium explorers looking for primary helium sources that are not linked to natural gas production.
  • Most new helium companies have understandably gone where there were already known helium deposits, identified via natural gas exploration and production.
  • In addition, a consulting or other service contract exists between Pulsar Helium and GOLDINVEST Consulting GmbH, with which a further conflict of interest exists, since Pulsar Helium remunerates GOLDINVEST Consulting GmbH for reporting.